13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CMET-26. PERIOPERATIVE IMAGING OF BRAIN METASTASES: A EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY (EANO) YOUNGSTERS SURVEY

      abstract

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          Neurosurgical resection is an important treatment option in the multimodal therapy of brain metastases (BM). Perioperative imaging is established in primary brain tumors to assess the extent of resection. However, structured guidelines on the use of perioperative imaging for BM patients are so far missing.

          METHODS

          The European Association of Neuro-Oncology (EANO) Youngsters committee designed a comprehensive questionnaire on the use of perioperative imaging. The survey was distributed to physicians with neuro-oncologic focus via the EANO and the European Association of Neurosurgical Societies (EANS) network.

          RESULTS

          120 physicians from non-European countries and European countries responded to the survey. 76/120 neurosurgeons, 18/120 radiation oncologists and 17/120 neurologists participated. 89/120 participants worked at academic hospitals and 39/40 participants worked in high patient volume centers as defined by >50 BM cases per year. Local standard operating procedures for perioperative imaging were applied by 94/120 physicians. The preferred preoperative imaging method represented MRI for 112/120 (93.3%) participants. Postsurgical imaging was routinely performed by 106/120 physicians. 77/120 participants indicated MRI as the preferred postoperative imaging method, however, only 71/120 performed postoperative MRI imaging within 72 hours after resection. No correlation of postsurgical MRI and localization at an academic hospital (58/79 [73.4%] vs. 19/27 [70.4%], p>0.05) or patient volume (49/71 [69%] vs 25/40 [62.5%], p>0.05) was evident. The most frequently indicated reason for postsurgical imaging was the assessment of extent of resection as participants indicated to adjust the radiotherapy plan or even considered re-surgery to achieve complete resection. CONCLUSIONS: This EANO survey indicates that preoperative MRI is the preferred imaging technique for the majority of physicians, whereas a high variability of postoperative neuroimaging routines including CT and MRI was observed. International guidelines for perioperative imaging with special focus on postoperative MRI are warranted in order to optimize perioperative treatment modalities for BM patients.

          Related collections

          Author and article information

          Journal
          Neuro Oncol
          Neuro-oncology
          neuonc
          Neuro-Oncology
          Oxford University Press (US )
          1522-8517
          1523-5866
          November 2018
          05 November 2018
          : 20
          : Suppl 6 , Abstracts from the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, Louisiana
          : vi59
          Affiliations
          [1 ]Medical University Vienna, Vienna, Austria
          [2 ]Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany
          [3 ]Department of Neurology, University Hospital Zurich, Zurich, Switzerl
          [4 ]Department of Neurosurgery, St. Olav’s University Hospital, Trondheim, Norway; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden
          [5 ]Department of Medical Oncology, Institut régional du Cancer Montpellier, University of Montpellier, Montpellier, France
          [6 ]Dept Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy
          [7 ]Medical University of Vienna, Vienna, Austria
          [8 ]Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria
          [9 ]Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerl
          [10 ]University of Portsmouth, Portsmouth, England, United Kingdom
          [11 ]University Paul Sabatier Toulouse III, Toulouse, France
          [12 ]Sweden and Umeå University, Umea, Sweden
          [13 ]Cambridge University Hospitals, Cambridge, England, United Kingdom
          [14 ]Department of Neuropathology, Heinrich Heine University Hospital, Düsseldorf, Germany
          [15 ]Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Neuro-Oncologie, Lyon, France
          [16 ]Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany
          Article
          PMC6216923 PMC6216923 6216923 noy148.238
          10.1093/neuonc/noy148.238
          6216923
          57291956-efef-44fe-ad3e-f9d6397277a6
          © The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

          This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

          History
          Page count
          Pages: 1
          Categories
          Abstracts
          CNS Metastasis

          Comments

          Comment on this article